Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (4): 108-114.doi: 10.6040/j.issn.1673-3770.0.2023.214
• Original Article • Previous Articles Next Articles
LI Yaru, XU Zhenju, WANG Xiaojun, FU Tao, YUAN Yue, WU Ce
CLC Number:
| [1] Destombes P. Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali.(4 cases)[J]. Bull Soc Pathol Exot Filiales, 1965, 58(6): 1169-1175 [2] Rosai J, Dorfman RF. Sinus Histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity[J]. Arch Pathol, 1969, 87(1): 63-70 [3] Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages[J]. Blood, 2016, 127(22): 2672-2681. doi:10.1182/blood-2016-01-690636 [4] Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease[J]. Blood, 2018, 131(26): 2877-2890. doi:10.1182/blood-2018-03-839753 [5] 张亚男, 潘国庆, 李睿, 等. 结外Rosai-Dorfman病的相关临床病理特征及文献复习[J]. 分子诊断与治疗杂志, 2022, 14(6): 1068-1071. doi: 10.3969/j.issn.1674-6929.2022.06.042 ZHANG Yanan, PAN Guoqing, LI Rui, et al. The clinicopathological characteristics and literature review of extranodal rosai-dorfman disease[J]. Journal of Molecular Diagnosis and Therapy, 2022, 14(6): 1068-1071. doi: 10.3969/j.issn.1674-6929.2022.06.042 [6] Rajyalakshmi R, Akhtar M, Swathi Y, et al. Cytological diagnosis of rosai-dorfman disease: a study of twelve cases with emphasis on diagnostic challenges[J]. J Cytol, 2020, 37(1): 46-52. doi:10.4103/JOC.JOC_4_19 [7] Tummidi S, Singh HK, Reddy PA, et al. ROSE in rosai-dorfman-destombes(RDD)disease: a cytological diagnosis[J]. Eur J Med Res, 2021, 26(1): 34. doi:10.1186/s40001-021-00505-x [8] Cohen Aubart F, Haroche J, Emile JF, et al. Rosai-Dorfman disease: diagnosis and therapeutic challenges[J]. Rev Med Interne, 2018, 39(8): 635-640. doi:10.1016/j.revmed.2018.02.011 [9] Dalia S, Sagatys E, Sokol L, et al. Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment[J]. Cancer Control, 2014, 21(4): 322-327. doi:10.1177/107327481402100408 [10] 刘旭, 胡余昌, 唐立华. Rosai-Dorfman病研究进展[J]. 中华病理学杂志, 2017, 46(6): 443-446. doi:10.3760/cma.j.issn.0529-5807.2017.06.023 [11] Goyal G, Young JR, Koster MJ, et al. The mayo clinic Histiocytosis working group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: erdheim-Chester disease, Langerhans cell Histiocytosis, and rosai-dorfman disease[J]. Mayo Clin Proc, 2019, 94(10): 2054-2071. doi:10.1016/j.mayocp.2019.02.023 [12] 杨冉冉, 鞠侯雨, 任国欣, 等. 36例口腔颌面-头颈部朗格汉斯细胞组织细胞增多症临床及预后分析[J]. 中国口腔颌面外科杂志, 2021, 19(1): 52-58. doi:10.19438/j.cjoms.2021.01.011 YANG Ranran, JU Houyu, REN Guoxin, et al. Clinical and prognostic analysis of Langerhans cell Histiocytosis in oral maxillofacial head and neck: report of 36 consecutive cases[J]. China Journal of Oral and Maxillofacial Surgery, 2021, 19(1): 52-58. doi:10.19438/j.cjoms.2021.01.011 [13] 马晓松, 汪步海, 梁一晨, 等. B细胞非霍奇金淋巴瘤靶向药物治疗研究进展[J]. 现代肿瘤医学, 2022, 30(12):2272-2275. doi: 10.3969/j.issn.1672-4992.2022.12.034 MA Xiaosong, WANG Buhai, LIANG Yichen, et al. Advances in targeted drug therapy for B-cell non-Hodgkin's lymphoma[J]. Journal of Modern Oncology, 2022, 30(12)2272-2275. doi: 10.3969/j.issn.1672-4992.2022.12.034 [14] Abraham ZS, Francis Z, Ngaiza AI, et al. Histocytopathological diagnosis of Rosai-Dorfman disease: case report[J]. Clin Case Rep, 2022, 10(2): e05412. doi:10.1002/ccr3.5412 [15] Al-Khateeb TH. Cutaneous rosai-dorfman disease of the face: a comprehensive literature review and case report[J]. J Oral Maxillofac Surg, 2016, 74(3): 528-540. doi:10.1016/j.joms.2015.09.017 [16] Ahmed A, Crowson N, Magro CM. A comprehensive assessment of cutaneous Rosai-Dorfman disease[J]. Ann Diagn Pathol, 2019, 40: 166-173. doi:10.1016/j.anndiagpath.2019.02.004 [17] Varrassi M, Corridore A, Tommasino E, et al. MR imaging of cerebral involvement of Rosai-Dorfman disease: a single-centre experience with review of the literature[J]. Radiol Med, 2021, 126(1): 89-98. doi:10.1007/s11547-020-01226-7 [18] Zhang XS, Yin W, Guo YW, et al. Rosai-Dorfman disease of the central nervous system: a clinical, radiological, and prognostic study of 12 cases[J]. Front Oncol, 2022, 12: 1013419. doi:10.3389/fonc.2022.101341 [19] Al-Maghrabi H, Elmahrouk A, Feteih M, et al. Rosai-Dorfman disease with pulmonary involvement mimicking bronchogenic carcinoma[J]. J Cardiothorac Surg, 2020, 15(1): 37. doi:10.1186/s13019-020-1085-6 [20] 崔哲卿, 濮田, 刘蕾, 等. 累及腮腺、双侧鼻腔及颈部淋巴结rosai-dorfman病一例 [J]. 中国临床案例成果数据库, 2022, 4(1): 873. doi:10.3760/cma.j.cmcr.2022.e00873 CUI Zheqing, PU Tian, LIU Lei, et al. A case of rosai-dorfman disease involving parotid gland, bilateral nasal cavity and cervical lymph nodes [J]. China clinical case database. 2022, 4(1): 873. doi:10.3760/cma.j.cmcr.2022.e00873 [21] 李秋慧, 朱芳, 刘涛, 等. 放射治疗皮肤rosai-dorfman疾病的病例报告[J]. 中国临床案例成果数据库, 2022, 4(1): 6889. doi: 10.3760/cma.j.cmcr.2022.e06889 LI Qiuhui, ZHU Fang, LIU Tamia, et al. Case report of skin rosai-dorfman disease treated by radiotherapy [J]. China clinical case achievement database, 2022, 4(1): 6889. doi: 10.3760/cma.j.cmcr.2022.e06889 [22] Wan M, Ding AJ, Liu H, et al. Successful treatment of large cutaneous facial Rosai-Dorfman disease using combination of subtotal resection and ALA-PDT: a case report[J]. Photodiagnosis Photodyn Ther, 2020, 31: 101879. doi:10.1016/j.pdpdt.2020.101879 [23] Li M, Shi L, Luo M, et al. Successful treatment of Rosai-Dorfman disease using in situ photoimmunotherapy[J]. Indian J Dermatol Venereol Leprol, 2017, 83(3): 332-336. doi:10.4103/ijdvl.IJDVL_356_16 |
| [1] | WANG Zhiyuan, HAO Zhongkai, ZHANG Chenming. The effect of local micro-pressure oxygen on the repair and oxidative stress of rabbit corneal epithelial cells after injury [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 80-86. |
| [2] | GU Min, LU Meiping. Advances in the application of nanomedicine delivery systems in allergen immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 106-111. |
| [3] | WANG Xiaojie, ZHANG Mingjun, SONG Zheying, CUI Limei, SONG Xicheng. Anti-cancer mechanism and research progress of kaempferol [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 168-178. |
| [4] | XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33. |
| [5] | LIU Yuzhu, YUAN Tiejun, LI Bo. Primary epiglottic neuroendocrine carcinoma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 97-100. |
| [6] | ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147. |
| [7] | QIU Qianhui, XIAO Xuping, YANG Qintai, YE Jing, DENG Zeyi, WANG Desheng, TAN Guolin, JIANG weihong,. Expert consensus on clinical management recommendations for carotid blowout syndrome secondary to NPC treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 1-18. |
| [8] | HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30. |
| [9] | SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41. |
| [10] | XU Fei, ZHU Guangxi, WANG Kexin. Construction of a decision tree algorithm to predict the risk of radiation oral mucositis in nasopharyngeal carcinoma patients after radiotherapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 42-48. |
| [11] | ZHU Ruikai, WU Jiarong, SUN Fang, XIE Chubo, QIU Qianhui. Computed tomography angiography-based assessment of internal carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma and its associated factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 77-84. |
| [12] | DONG Xuelin, ZHANG Zhijun. Analysis of anxiety and depression states in the treatment of chronic subjective tinnitus with masking sound therapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 18-24. |
| [13] | ZHANG Maohua, WEI Rifu, ZHU Zhongshou, LIU Ping, GAO Shang, LI Huifeng. Effect of LncRNA PCAT-1 on the biological behaviour and chemosensitivity of nasopharyngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 68-76. |
| [14] | ZHANG Yunqiu, REN Xiumin, XU Ou, DONG Jinhui, WANG Jianxing. Research progress on omalizumab targeted therapy for chronic sinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 136-140. |
| [15] | DU Chen, YAN Yan, WANG Li, LU Peiquan. Impact of acid reflux event thresholds on the diagnosis and management of oesophageal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 115-119. |
|
||